{
    "title": "Beta-Cell Fragility As a Common Underlying Risk Factor in Type 1 and Type 2 Diabetes.",
    "doc_id": "28117227",
    "writer": "Liston A",
    "year": "2017",
    "summary": "Type 1 and type 2 diabetes are distinct clinical entities primarily driven by autoimmunity and metabolic dysfunction, respectively. ...The beta-cell fragility model proposes that this variation contributes to the risk of developing either type 1 or  â€¦",
    "abstract": "Type 1 and type 2 diabetes are distinct clinical entities primarily driven by autoimmunity and metabolic dysfunction, respectively. However, there is a growing appreciation that they may share an etiopathological factor, namely the role of variation in beta-cell sensitivity to stress factors. Increased sensitivity increases the risk of beta-cell death or insulin secretion dysfunction. The beta-cell fragility model proposes that this variation contributes to the risk of developing either type 1 or type 2 diabetes, in the presence of immunological and/or metabolic stress factors. Therapeutics that increase the resistance of beta cells to these factors and decreasing fragility may constitute a new class of anti-diabetogenics, with potential use across both diseases.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/28117227/"
}